HK1201837A1 - Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor - Google Patents

Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor

Info

Publication number
HK1201837A1
HK1201837A1 HK15102455.7A HK15102455A HK1201837A1 HK 1201837 A1 HK1201837 A1 HK 1201837A1 HK 15102455 A HK15102455 A HK 15102455A HK 1201837 A1 HK1201837 A1 HK 1201837A1
Authority
HK
Hong Kong
Prior art keywords
agonists
stimulating hormone
hormone receptor
follicle stimulating
analogues
Prior art date
Application number
HK15102455.7A
Other languages
English (en)
Chinese (zh)
Inventor
‧余
‧唐納利
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1201837A1 publication Critical patent/HK1201837A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK15102455.7A 2012-02-08 2015-03-10 Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor HK1201837A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596417P 2012-02-08 2012-02-08
PCT/EP2013/000215 WO2013117299A1 (en) 2012-02-08 2013-01-24 Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor

Publications (1)

Publication Number Publication Date
HK1201837A1 true HK1201837A1 (en) 2015-09-11

Family

ID=47666083

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102455.7A HK1201837A1 (en) 2012-02-08 2015-03-10 Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor

Country Status (15)

Country Link
US (1) US20150111933A1 (xx)
EP (1) EP2812320B1 (xx)
JP (1) JP6386382B2 (xx)
KR (1) KR20140120903A (xx)
CN (1) CN104114544A (xx)
AU (1) AU2013218368B2 (xx)
BR (1) BR112014019351A8 (xx)
CA (1) CA2860489C (xx)
ES (1) ES2672326T3 (xx)
HK (1) HK1201837A1 (xx)
IL (1) IL233983B (xx)
MX (1) MX2014009416A (xx)
RU (1) RU2014136334A (xx)
SG (1) SG11201403540RA (xx)
WO (1) WO2013117299A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015196335A1 (en) 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
CA2339018A1 (en) 1998-08-07 2000-02-17 Applied Research Systems Ars Holding N.V. Fsh mimetics for the treatment of infertility
US6440710B1 (en) * 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
US6426357B1 (en) 1999-07-27 2002-07-30 Affymax, Inc. Antagonists of follicle stimulating hormone activity
DK1104760T3 (da) * 1999-12-03 2003-06-30 Pfizer Prod Inc Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
EP1307193A1 (en) * 2000-07-27 2003-05-07 Affymax Research Institute Agonists of follicle stimulating hormone activity
TW200413273A (en) * 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
BRPI0617987A2 (pt) * 2005-10-06 2011-08-16 Auspex Pharmaceuticals Inc composição, composição farmacêutica, forma de dosagem efervescente, composição farmacêutica oral de comprimidos unitários múltiplos, forma de dosagem farmacêutica de liberação prolongada, forma de dosagem farmacêutica revestida entérica, forma de dosagem farmacêutica estável para administração oral a sujeitos mamìferos, método para tratamento de doenças relacionadas a ácido gástrico pela inibição de secreção de ácido gástrico, método para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori, processo para preparar um composto da fórmula 3, processo para preparar um composto da fórmula 5, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relacionadas a ácido gástrico, pela inibição de secreção de ácido gástrico, uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de uma infecção bacteriana provocada ou mediada por helicobacter pylori uso de um composto da fórmula 1 para a preparação de um medicamento para tratamento de doenças relecionadas a ácido gástrico pela inibição de secreção de ácido gástrico
US7750168B2 (en) * 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
EP2209774A1 (en) * 2007-10-02 2010-07-28 Concert Pharmaceuticals Inc. Pyrimidinedione derivatives
WO2010028015A2 (en) * 2008-09-03 2010-03-11 Auspex Pharmaceuticals, Inc 2-oxo-1,2-dihydro-quinoline modulators of immune function
TWI461426B (zh) * 2009-05-27 2014-11-21 Merck Sharp & Dohme （二氫）咪唑並異〔５，１－ａ〕喹啉類

Also Published As

Publication number Publication date
AU2013218368B2 (en) 2017-09-07
WO2013117299A1 (en) 2013-08-15
IL233983B (en) 2019-12-31
CA2860489C (en) 2019-11-12
KR20140120903A (ko) 2014-10-14
JP2015511943A (ja) 2015-04-23
JP6386382B2 (ja) 2018-09-05
EP2812320B1 (en) 2018-03-07
CA2860489A1 (en) 2013-08-15
SG11201403540RA (en) 2014-07-30
ES2672326T3 (es) 2018-06-13
IL233983A0 (en) 2014-09-30
EP2812320A1 (en) 2014-12-17
CN104114544A (zh) 2014-10-22
BR112014019351A8 (pt) 2017-07-11
AU2013218368A1 (en) 2014-07-17
MX2014009416A (es) 2014-11-10
BR112014019351A2 (xx) 2017-06-20
RU2014136334A (ru) 2016-04-10
US20150111933A1 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
IL233759A0 (en) Emulsion containing hormones
PL2806886T3 (pl) Stabilizowane kompozycje białkowe oparte na semifluorowanych alkanach
IL258357A (en) A semi-solid aqueous pharmaceutical preparation containing tapentadol
HK1201826A1 (en) Benzamide derivatives as modulators of the follicle stimulating hormone
HK1199878A1 (en) Spiroindoline derivatives as gonadotropin-releasing hormone receptor antagonists
GB201203181D0 (en) Blade tip timing uncertainty
IL244986A0 (en) Formulation for gonadotropins
HK1207985A1 (en) Somatostatin receptor agonist formulations
HRP20190141T1 (hr) Oblik doziranja antagonista receptora progesterona
HK1198424A1 (en) Thyroid stimulating hormone compositions
HK1201837A1 (en) Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor
IL243730B (en) Vasopressin-2 receptor agonist peptides
HK1216101A1 (zh) 用作促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物
HUE050861T2 (hu) Rianodinreceptor-antagonista dantrolent tartalmazó gyógyászati készítmény sebgyógyulás elõsegítésére
IL233770A0 (en) Xanthocillin analogs with formalin groups for use as neuroprotective agents
HK1250664A1 (zh) 含有他噴他多的半固體水性藥物組合物
GB201105108D0 (en) Wing tip pod